SLI
Sumitomo Life Insurance Portfolio holdings
AUM
$1.47B
1-Year Return
20.66%
This Quarter Return
+8.26%
1 Year Return
+20.66%
3 Year Return
+58.92%
5 Year Return
+100.42%
10 Year Return
+275.58%
AUM
$3.85B
AUM Growth
+$636M
(+20%)
Cap. Flow
+$664M
Cap. Flow
% of AUM
17.23%
Top 10 Holdings %
Top 10 Hldgs %
76.62%
Holding
265
New
7
Increased
42
Reduced
213
Closed
2
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$267M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
$248M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$127M |
| 4 |
iShares TIPS Bond ETF
TIP
|
$69.6M |
| 5 |
iShares S&P GSCI Commodity-Indexed Trust
GSG
|
$46.6M |
Top Sells
Sector Composition
| 1 | Technology | 6.9% |
| 2 | Healthcare | 2.93% |
| 3 | Financials | 2.55% |
| 4 | Consumer Discretionary | 2.18% |
| 5 | Communication Services | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Mondelez International
MDLZ
$79.9B
| $1.92M | 0.05% |
27,498
-1,083
| -4% | -$75.8K |
|
127
HCA Healthcare
HCA
$98.5B
| $1.9M | 0.05% |
5,709
-226
| -4% | -$75.4K |
|
128
Philip Morris
PM
$251B
| $1.9M | 0.05% |
20,749
-817
| -4% | -$74.9K |
|
129
RTX Corp
RTX
$211B
| $1.9M | 0.05% |
19,461
-766
| -4% | -$74.7K |
|
130
Regeneron Pharmaceuticals
REGN
$60.8B
| $1.9M | 0.05% |
1,972
-79
| -4% | -$76K |
|
131
Amgen
AMGN
$153B
| $1.86M | 0.05% |
6,532
-263
| -4% | -$74.8K |
|
132
Marriott International Class A Common Stock
MAR
$71.9B
| $1.85M | 0.05% |
7,349
-291
| -4% | -$73.4K |
|
133
CSX Corp
CSX
$60.6B
| $1.84M | 0.05% |
49,680
-1,957
| -4% | -$72.5K |
|
134
Verizon
VZ
$187B
| $1.83M | 0.05% |
43,548
-1,713
| -4% | -$71.9K |
|
135
Medtronic
MDT
$119B
| $1.81M | 0.05% |
20,720
-815
| -4% | -$71K |
|
136
Chubb
CB
$111B
| $1.76M | 0.05% |
6,790
-268
| -4% | -$69.4K |
|
137
Blackrock
BLK
$170B
| $1.73M | 0.04% |
2,074
-82
| -4% | -$68.4K |
|
138
Morgan Stanley
MS
$236B
| $1.72M | 0.04% |
18,301
-720
| -4% | -$67.8K |
|
139
Welltower
WELL
$112B
| $1.72M | 0.04% |
18,390
-724
| -4% | -$67.7K |
|
140
Goldman Sachs
GS
$223B
| $1.68M | 0.04% |
4,018
-157
| -4% | -$65.6K |
|
141
Abbott
ABT
$231B
| $1.66M | 0.04% |
14,617
-577
| -4% | -$65.6K |
|
142
Target
TGT
$42.3B
| $1.64M | 0.04% |
9,259
-364
| -4% | -$64.5K |
|
143
Pfizer
PFE
$141B
| $1.63M | 0.04% |
58,907
-2,318
| -4% | -$64.3K |
|
144
Datadog
DDOG
$47.5B
| $1.58M | 0.04% |
12,766
-503
| -4% | -$62.2K |
|
145
CVS Health
CVS
$93.6B
| $1.55M | 0.04% |
19,375
-763
| -4% | -$60.9K |
|
146
Cigna
CI
$81.5B
| $1.5M | 0.04% |
4,140
-182
| -4% | -$66.1K |
|
147
Travelers Companies
TRV
$62B
| $1.5M | 0.04% |
6,517
-255
| -4% | -$58.7K |
|
148
Equinix
EQIX
$75.7B
| $1.49M | 0.04% |
1,802
-79
| -4% | -$65.2K |
|
149
Boeing
BA
$174B
| $1.47M | 0.04% |
7,633
-337
| -4% | -$65K |
|
150
T-Mobile US
TMUS
$284B
| $1.47M | 0.04% |
9,014
-397
| -4% | -$64.8K |
|